Castleark Management LLC Sells 16,730 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Castleark Management LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 98,850 shares of the exchange traded fund’s stock after selling 16,730 shares during the quarter. Castleark Management LLC owned 0.13% of SPDR S&P Biotech ETF worth $8,902,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in XBI. Demars Financial Group LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $280,309,000. BlueCrest Capital Management Ltd purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $138,051,000. RA Capital Management L.P. purchased a new position in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $110,615,000. Proficio Capital Partners LLC increased its position in SPDR S&P Biotech ETF by 16,156.1% in the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $55,529,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $81.40 on Wednesday. The stock’s fifty day moving average is $79.64 and its 200 day moving average is $88.28. The firm has a market capitalization of $5.13 billion, a PE ratio of 11.47 and a beta of 0.91. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.